Citations

Mayo Clinic

Showing 10 of 108599 citations.

Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?
Camilleri, Michael , Halawi, Houssam , Oduyebo, Ibironke

Expert Review of Gastroenterology & Hepatology | January 27, 2017 | Volume: 11 | Issue: 4 | Pages: 303-316

10.1080/17474124.2017.1288096 | PMID 28128666 Get It

Construction of bioengineered hepatic tissue derived from human umbilical cord mesenchymal stem cells via aggregation culture in porcine decellularized liver scaffolds
Li, Yi , Wu, Qiong , Wang, Yujia , Li, Li , Shi, Yujun , Bu, Hong , Chen, Fei , Bao, Ji

Xenotransplantation | January 27, 2017 | Volume: 24 | Issue: 1 | Pages: No page available

10.1111/xen.12285 | PMID 28127796 Get It

AbstractBackgroundAn individualized, tissue‐engineered liver suitable for transplanting into a patient with liver disease would be of great benefit to the patient and the healthcare system. The tissue‐engineered liver would possess the functions of the original healthy organ. Two fields of study, (i) using decellularized tissue as cell scaffolding, and (ii) stem cell differentiation into functional cells, are coming together to make this concept feasible. The decellularized liver scaffolds (DLS) can interact with cells to promote cell differentiation and signal transduction and three‐dimensional (3D) stem cell aggregations can maintain the phenotypes and improve functions of stem cells after differentiation by undergoing cell‐cell contact. Although the effects of DLS and stem cell aggregation culture have been intensively studied, few observations about the interaction between the two have been achieved.MethodsWe established a method that combines the use of decellularized liver scaffolds and aggregation culture of MSCs (3D‐DLS) and explored the effects of the two on hepatic differentiation of human umbilical cord mesenchymal stem cells (hUC‐MSCs) in bioengineered hepatic tissue.ResultsA higher percentage of albumin‐producing cells, higher levels of liver‐specific transcripts, higher urea cycle‐related transcripts, and lower levels of stem cell‐specific transcripts were observed in the 3D‐DLS group when compared to that of hUC‐MSCs in monolayer culture (2D), aggregation culture (3D), monolayer on DLS culture (2D‐DLS). The gene arrays also indicated that 3D‐DLS induced the differentiation from the hUC‐MSC phenotype to the PHH phenotype. Liver‐specific proteins albumin, CK‐18, and glycogen storage were highly positive in the 3D‐DLS group. Albumin secretion and ammonia conversion to urea were more effective with a higher cell survival rate in the 3D‐DLS group for 14 days.ConclusionThis DLS and aggregation combination culture system provides a novel method to improve hepatic differentiation, maintain phenotype of hepatocyte‐like cells and sustain survival for 14 days in vitro. This is a promising strategy to use to construct bioengineered hepatic tissue.
Meningiomas of the Cerebellopontine Angle
Laird, Frank J., Harner, Stephen G., Laws, Edward R. , Reese, David F.

Otolaryngology–Head and Neck Surgery | January 26, 2017 | Volume: 93 | Issue: 2 | Pages: 163-167

10.1177/019459988509300207 | PMID 3921906 Get It

The majority of cerebellopontine angle tumors are acoustic neurinomas; however, 10% to 15% are meningiomas. Meningiomas are benign lesions that must be removed but may require surgical approaches different from those used for acoustic neurinomas. To determine if meningiomas could be distinguished from acoustic neurinomas clinically, findings in 20 patients who underwent removal of a meningioma were compared to those in 131 patients who had an acoustic neurinoma removed during the same period. We found that in patients with meningiomas the tumors frequently are large at presentation, the otologic symptoms and audiometric findings are less dramatic, and roentgenograms of the skull and tomograms of the petrous apex rarely show erosion of the internal auditory canal. Computerized tomography is the most useful method for differentiating a meningioma from a neurinoma: when a meningioma is present the characteristic finding is a broad‐based mass aligned with the petrous ridge, not centered over the internal auditory canal.
Transcutaneous Teflon injection for vocal cord paralysis
McCaffrey, Thomas V.

Otolaryngology–Head and Neck Surgery | January 26, 2017 | Volume: 109 | Issue: 1 | Pages: 54-59

10.1177/019459989310900110 | PMID 8336968 Get It

In 1989, I reported a series of 19 cases of unilateral vocal cord paralysis treated by transcutaneous Teflon injection. At that time it was shown that unilateral vocal cord paralysis could be effectively treated in the office in the unanesthetized patient using a transcutaneous route of Injection. Since that time, an additional 43 patients have been treated using a similar technique. The initial impression of safety and efficacy has been confirmed in this subsequent series. Several refinements in this technique have simplified its use and improved its reliability. No airway complications have been observed to date and no patients have required hospital admission. Transcutaneous Teflon Injection can be considered a useful method for treatment of vocal cord paralysis in selected patients.
Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopeni
Maria, Sifat, Swanson, Mark H., Enderby, Larry T., D’Amico, Frank, Enderby, Brianna, Samsonraj, Rebekah M. , Dudakovic, Amel , Wijnen, André J. van , Witt‐Enderby, Paula A. , van Wijnen, Andre J, van Wijnen, Andre J , Witt-Enderby, Paula A

Aging | January 26, 2017 | Volume: 9 | Issue: 1 | Pages: 256-285

10.18632/aging.101158 | PMID 28130552 Get It

Applying Criteria of Active Surveillance to Low-Risk Papillary Thyroid Cancer Over a Decade: How Many Surgeries and Complications Can Be Avoided?
Brito, Juan P. , Bahl, Manisha , Griffin, Andrew S. , Hoang, Jenny K. , Brito, Juan P

Thyroid | January 26, 2017 | Volume: 27 | Issue: 4 | Pages: 518-523

10.1089/thy.2016.0568 | PMID 28125944 Get It

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death
Muchtar, Eli , Gertz, Morie A. , Kumar, Shaji , Lacy, Martha Q. , Dingli, David , Grogan, Martha , Hayman, Suzanne R. , Kapoor, Prashant , Fonder, Amie , Hobbs, Miriam, Hwa, Yi L. , Warsame, Rahma , Kourelis, Taxiarchis , Russell, Stephen J. , Lust, John A., Lin, Yi , Zeldenrust, Steven R., Kyle, Robert A. , Buadi, Francis K. , Leung, Nelson , Gonsalves, Wilson I. , Go, Ronald S. , Rajkumar, S. Vincent , Dispenzieri, Angela , Gertz, Morie A , Muchtar, E , Russell, Stephen J , Dingli, David , Lin, Yi

Blood | January 26, 2017 | Volume: 129 | Issue: 15 | Pages: 2111-2119

10.1182/blood-2016-11-751628 | PMID 28126928 Get It

Key Points Significant improvement in outcome is a reality for newly diagnosed AL amyloidosis in the past decade. Six-month mortality among transplant ineligible patients has declined since 2005.
Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development
Arshad, Muhammad Usman , Frost, Marlene H., Winham, Stacey J. , Brahmbhatt, Rushin, Peña, Alvaro, Carter, Jodi M. , Stallings‐Mann, Melody , Murphy, Linda M., Miller, Erin , Denison, Lori A., Vachon, Celine M. , Knutson, Keith L. , Visscher, Daniel W., Hoskin, Tanya L. , Brahmbhatt, Rushin A, Stallings-Mann, Melody L, Miller, Erin E, Radisky, Derek C. , Degnim, Amy C. , Vachon, Celine M. , Knutson, Keith L. , Winham, Stacey J , Carter, Jodi

Clinical Cancer Research | January 26, 2017 | Volume: 23 | Issue: 14 | Pages: 3945-3952

10.1158/1078-0432.ccr-16-2026 | PMID 28126725 Get It

Abstract Purpose: Little is known about the role of the immune system in the earliest stages of breast carcinogenesis. We studied quantitative differences in immune cell types between breast tissues from normal donors and those from women with benign breast disease (BBD). Experimental Design: A breast tissue matched case–control study was created from donors to the Susan G. Komen for the Cure Tissue Bank (KTB) and from women diagnosed with BBD at Mayo Clinic (Rochester, MN) who either subsequently developed cancer (BBD cases) or remained cancer-free (BBD controls). Serial tissue sections underwent immunostaining and digital quantification of cell number per mm2 for CD4+ T cells, CD8+ T cells, CD20+ B cells, and CD68+ macrophages and quantification of positive pixel measure for CD11c (dendritic cells). Results: In 94 age-matched triplets, BBD lobules showed greater densities of CD8+ T cells, CD11c+ dendritic cells, CD20+ B cells, and CD68+ macrophages compared with KTB normals. Relative to BBD controls, BBD cases had lower CD20+ cell density (P = 0.04). Nearly 42% of BBD cases had no CD20+ B cells in evaluated lobules compared with 28% of BBD controls (P = 0.02). The absence of CD20+ cells versus the presence in all lobules showed an adjusted OR of 5.7 (95% confidence interval, 1.4–23.1) for subsequent breast cancer risk. Conclusions: Elevated infiltration of both innate and adaptive immune effectors in BBD tissues suggests an immunogenic microenvironment. The reduced B-cell infiltration in women with later breast cancer suggests a role for B cells in preventing disease progression and as a possible biomarker for breast cancer risk. Clin Cancer Res; 23(14); 3945–52. ©2017 AACR.
Getting 5000 Families Back Together: Reuniting Fractured Families After a Disaster: The Role of the National Center for Missing & Exploited Children
Broughton, Daniel D., Allen, Ernest E., Hannemann, Robert E., Petrikin, Joshua E., Petrikin, Josh E

Pediatrics | January 26, 2017 | Volume: 117 | Issue: Supplement_4 | Pages: S442-S445

10.1542/peds.2006-0099s | PMID 16735280 Get It